0d955a11a8e271018396cc20.VyP6WPU9fy96JD_CQ3m0abr697EJpCzMO-NoPxq8ErQ.JHezCbtwGkwpfG21czbNIc6bz_NGk3qda9sYannvdcAmcaNpmUxGTEIcag
11-12 Asymchem Laboratories Co., Ltd. announces an Equity Buyback for CNY 700 million worth of its shares. CI
11-11 Asymchem Laboratories Co., Ltd. authorizes a Buyback Plan. CI
10-23 Asymchem Laboratories Tianjin Posts Higher Q3 Adjusted Attributable Profit; Revenue Up MT
10-22 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 CI
10-22 Asymchem Laboratories Posts Higher Q3 Attributable Profit; Revenue Up MT
08-25 Asymchem Laboratories' H1 Profit Declines 16% MT
08-24 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
07-31 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
07-29 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
07-27 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
06-11 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
05-27 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates GL
05-27 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates AQ
05-27 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
05-20 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
05-15 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
05-13 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
05-04 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
04-28 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
04-27 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-27 Asymchem Laboratories (Tianjin) Q1 net profit down 6.8% Y/Y RE
04-21 Asymchem Laboratories Profit Rises 19% in 2025 MT
04-14 Asymchem Unveils Fully Integrated TIDES Commercial Supply Matrix CI

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. 002821 Stock
  4. ASLT.Y Stock
  5. News Asymchem Laboratories (Tianjin) Co., Ltd.